• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

禁食大鼠中他克林生物利用度增加的机制。

Mechanism for increased bioavailability of tacrine in fasted rats.

作者信息

Sung Jong-Hyuk, Hong Soon-Sun, Ahn Sung-Hoon, Li Hong, Seo Seung-Yong, Park Chul-Hong, Park Byung-Soon, Chung Suk-Jae

机构信息

College of Pharmacy, Seoul National University, Seoul 151-742, Korea.

出版信息

J Pharm Pharmacol. 2006 May;58(5):643-9. doi: 10.1211/jpp.58.5.0009.

DOI:10.1211/jpp.58.5.0009
PMID:16640833
Abstract

The mechanism associated with the increased bioavailability of tacrine as a result of a 24-h period of fasting was examined in rats. The AUC value for tacrine after the fasting was 52% higher compared with normal feeding when 4 mg kg(-1) of tacrine was orally administered, but the value for velnacrine, a hydroxylated metabolite of tacrine, was reduced by 10%. The relative metabolic ratio of tacrine in urinary excretion (Au(tacrine) divided by Au(velnacrine)) was lower in fasted rats compared with normally fed rats. This clearly shows that metabolism of tacrine is reduced with 24-h fasting after oral administration. Altered intestinal permeation in the fasting state was hypothesized, and the transport of tacrine across the rat intestine was studied. When a fasted intestine was mounted in an Ussing chamber, the mucosal-to-serosal permeability of tacrine was increased to double that for a fed rat intestine. To examine the effect of absorption rate on the hepatic metabolism of tacrine, a direct pyloric vein infusion study was carried out. Compared with an infusion of tacrine for 5 min, a slow infusion of tacrine over a period of 30 or 60 min increased the hepatic metabolism of tacrine and decreased its systemic clearance in rats. Collectively, these results suggest that rapid transport across the intestine aids tacrine in avoiding hepatic first-pass metabolism and enhances its bioavailability in fasted rats. From these findings, we conclude that both oral administration before a meal and a reduction in the dose might be recommended in tacrine therapy considering the serious hepatotoxicity of tacrine in clinical use.

摘要

在大鼠中研究了禁食24小时导致他克林生物利用度增加的相关机制。口服给予4mg/kg他克林后,禁食后的他克林AUC值比正常喂食时高52%,但其羟基化代谢物维拉克林的值降低了10%。与正常喂食的大鼠相比,禁食大鼠尿液排泄中他克林的相对代谢率(他克林的Au除以维拉克林的Au)较低。这清楚地表明,口服给药后禁食24小时会降低他克林的代谢。推测禁食状态下肠道渗透发生改变,并研究了他克林在大鼠肠道中的转运。当将禁食的肠道安装在Ussing室中时,他克林的黏膜到浆膜的渗透率增加到喂食大鼠肠道的两倍。为了研究吸收速率对他克林肝脏代谢的影响,进行了直接幽门静脉输注研究。与输注他克林5分钟相比,在30或60分钟内缓慢输注他克林会增加大鼠肝脏对他克林的代谢并降低其全身清除率。总体而言,这些结果表明,在禁食大鼠中,快速通过肠道转运有助于他克林避免肝脏首过代谢并提高其生物利用度。根据这些发现,考虑到他克林在临床使用中的严重肝毒性,我们得出结论,在他克林治疗中可能建议饭前口服给药并减少剂量。

相似文献

1
Mechanism for increased bioavailability of tacrine in fasted rats.禁食大鼠中他克林生物利用度增加的机制。
J Pharm Pharmacol. 2006 May;58(5):643-9. doi: 10.1211/jpp.58.5.0009.
2
Nose-to-brain delivery of tacrine.他克林的鼻脑给药
J Pharm Pharmacol. 2007 Sep;59(9):1199-205. doi: 10.1211/jpp.59.9.0003.
3
Preclinical characterization of intestinal absorption and metabolism of promising anti-Alzheimer's dimer bis(7)-tacrine.有前景的抗阿尔茨海默病二聚体双(7)-他克林的肠道吸收和代谢的临床前特征
Int J Pharm. 2008 Jun 5;357(1-2):85-94. doi: 10.1016/j.ijpharm.2008.01.037. Epub 2008 Feb 2.
4
Distribution of tacrine and metabolites in rat brain and plasma after single- and multiple-dose regimens. Evidence for accumulation of tacrine in brain tissue.单剂量和多剂量给药方案后他克林及其代谢产物在大鼠脑和血浆中的分布。脑组织中他克林蓄积的证据。
Drug Metab Dispos. 1996 Jun;24(6):628-33.
5
Inhibition of tacrine oral clearance by cimetidine.西咪替丁对他克林口服清除率的抑制作用。
Clin Pharmacol Ther. 1996 Apr;59(4):444-9. doi: 10.1016/S0009-9236(96)90114-9.
6
Asymmetric intestinal first-pass metabolism causes minimal oral bioavailability of midazolam in cynomolgus monkey.非对称的肠道首过代谢导致咪达唑仑在食蟹猴中的口服生物利用度极低。
Drug Metab Dispos. 2007 Aug;35(8):1275-84. doi: 10.1124/dmd.106.013037. Epub 2007 Apr 30.
7
Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.新型选择性p38α抑制剂6-(4-(2,5-二氟苯基)恶唑-5-基)-3-异丙基-[1,2,4]-三唑并[4,3-a]吡啶的临床前药代动力学与代谢:在临床前物种及人肝微粒体中活性代谢物的鉴定
Biopharm Drug Dispos. 2006 Nov;27(8):371-86. doi: 10.1002/bdd.520.
8
Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting.他克林的鼻腔黏膜黏附性微乳剂以改善脑靶向性。
Alzheimer Dis Assoc Disord. 2008 Apr-Jun;22(2):116-24. doi: 10.1097/WAD.0b013e318157205b.
9
Contribution of a significant first-pass effect of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate in the liver to its poor bioavailability in rats.4,4'-二甲氧基-5,6,5',6'-二亚甲基二氧基联苯-2,2'-二羧酸二甲酯在肝脏中的显著首过效应导致其在大鼠体内生物利用度低。
J Pharm Pharmacol. 2009 Sep;61(9):1197-203. doi: 10.1211/jpp/61.09.0009.
10
Pharmacokinetics of a novel histone deacetylase inhibitor, apicidin, in rats.新型组蛋白脱乙酰酶抑制剂阿皮西丁在大鼠体内的药代动力学
Biopharm Drug Dispos. 2006 Mar;27(2):69-75. doi: 10.1002/bdd.485.

引用本文的文献

1
Assessment of the CYP1A2 Inhibition-Mediated Drug Interaction Potential for Pinocembrin Using , , and Approaches.使用[具体方法1]、[具体方法2]和[具体方法3]评估白杨素的CYP1A2抑制介导的药物相互作用潜力。
ACS Omega. 2022 Jun 2;7(23):20321-20331. doi: 10.1021/acsomega.2c02315. eCollection 2022 Jun 14.
2
Fasting increases tobramycin oral absorption in mice.禁食可增加小鼠体内替考拉宁的口服吸收。
Antimicrob Agents Chemother. 2010 Apr;54(4):1644-6. doi: 10.1128/AAC.01172-09. Epub 2010 Jan 19.